The largest cohort of its kind reveals notable genomic features among young premenopausal women with HR-positive early breast cancer and could represent key targets for therapy.
Medscape Medical News
The largest cohort of its kind reveals notable genomic features among young premenopausal women with HR-positive early breast cancer and could represent key targets for therapy.
Medscape Medical News